Field

Health and Medical Sciences

Keywords

Cancer, translational medicine, regenerative medicine, Stem Cells, Diabetes, molecular genetics, inflammatory diseases, neuroscience, infectious diseases,organ transplants and cardiology.

Structure

Foundation

Partners

Government of Catalonia, Hospital Universitari de Bellvitge, Catalan Health Service (CatSalut), Catalan Institute of Oncology (ICO), University of Barcelona (UB) and L’Hospitalet de Llobregat city council.

Founded

2004

Contact

www.idibell.cat
Hospital Duran i Reynals – Gran Via de l’Hospitalet, 199, 3ª pl. – 08908 Hospitalet de Llobregat
Tel. +34 936 073 800
info@idibell.cat

Basic research serving clinical questions

The Bellvitge Biomedical Research Institute (IDIBELL) is a research center in biomedicine created in 2004 to carry out basic and clinical high-level research with the goal of improving the quality of life of citizens.

Located in L’Hospitalet de Llobregat, south of Barcelona its activity is focused in cancer, neuroscience, translational medicine and regenerative medicine.

IDIBELL is a CERCA Centre from the Government of Catalonia and it became, in 2009, one of the first five Spanish research centers accredited as a health research institute by the Instituto de Salud Carlos III. In 2015, the European Commission recognized the centre with the ‘HR Excellence in Research’ award, which identifies IDIBELL as a provider and supporter of a stimulating research work environment.

In 2017, the Center for Regenerative Medicine of Barcelona (CMR[B]), now part of IDIBELL, launched the Program for Advancing the Clinical Translation of Regenerative Medicine of Catalonia (P-CMR[C]) together with IDIBELL.